Brief: GL Pharm Tech says conversion of 2nd series convertible bonds into shares
Sept 11 (Reuters) - GL Pharm Tech Corp 204840.KQ :
* Says 3.29 billion won worth of its 2nd series convertible
bonds
have been converted into 1.2 million shares of the co, at 2,775
won/share
* Says listing date of new shares is Oct. 5
Source text in Korean: https://goo.gl/j24rEW
Further company coverage: 204840.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: Yinglan.Ma@thomsonreuters.com@reuters.net))
Recent news on GL Pharm Tech
See all newsBrief: Gl Pharm Tech Corp - Announces Reverse Stock Split
Brief: Gl Pharm Tech To Conduct Capital Increase Of 9.2 Billion Won For Operational Funds
Brief: Gl Pharm Tech Corp Wins 2 Billion Won Order
Brief: GL Pharm Tech says conversion of 2nd series convertible bonds into shares
Brief: GL Pharm Tech says conversion of 2nd series convertible bonds into shares